A peptide fragment derived from the T-cell antigen receptor protein α-chain adopts β-sheet structure and shows potent antimicrobial activity

Peptides

Volumn 30, Issue 4, 2009, Pages 647-653

  Zhang, Genghui ^a   Lin, Xiaoyan ^a   Long, Yi ^a   Wang, Yanqiang ^a   Zhang, Yueheng ^a   Mi, Huaifeng ^a   Yan, Husheng ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Sheet; Antibiotic; Antimicrobial peptide; Peptide; T cell antigen receptor

Indexed keywords

ANTIINFECTIVE AGENT; GLYCYLLEUCYLARGINYLISOLEUCYLLEUCYLLEUCYLLEUCYLLYSYLVALINAMIDE; PEPTIDE FRAGMENT; PLASMID DNA; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG;

AMIDATION; ANTIMICROBIAL ACTIVITY; ARTICLE; BETA SHEET; CELL MEMBRANE; CIRCULAR DICHROISM; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DNA BINDING; DRUG BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SOLID PHASE SYNTHESIS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; CIRCULAR DICHROISM; DNA; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 62749103310     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.12.002     Document Type: Article

References (29)

1. Agerberth B., Lee J.Y., Bergman T., Carlquist M., Boman H.G., Mutt V., et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 202 (1991) 849-854
2. Bartlett G.R. Phosphorus assay in column chromatography. J Biol Chem 234 (1959) 466-468
3. Blazyk J., Wiegand R., Klein J., Hammer J., Epand R.M., Epand R.F., et al. A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids. J Biol Chem 276 (2001) 27899-27906
4. Bradshaw J.P. Cationic antimicrobial peptides: issues for potential clinical use. BioDrugs 17 4 (2003) 233-240
5. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 3 (2005) 238-250
6. j(i = 2j) peptides to acquire optimal hemolytic activity. Biochim Biophys Acta 1416 (1999) 161-175
7. Chu-Kung A.F., Bozzelli K.N., Lockwood N.A., Haseman J.R., Mayo K.H., and Tirrell M.V. Promotion of peptide antimicrobial activity by fatty acid conjugation. Bioconjugate Chem 15 (2004) 530-535
8. Epand R.M., and Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462 (1999) 11-28
9. Hancock R.E.W., and Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8 (2000) 402-410
10. Hancock R.E.W., and Sahl H.-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24 (2006) 1551-1557
11. Imura Y., Nishida M., Ogawa Y., Takakura Y., and Matsuzaki K. Action mechanism of tachyplesin I and effects of PEGylation. Biochim Biophys Acta 1768 (2007) 1160-1169
12. Jin Y., Mozsolits H., Hammer J., Zmuda E., Zhu F., Zhang Y., et al. Influence of tryptophan on lipid binding of linear amphipathic cationic antimicrobial peptides. Biochemistry 42 (2003) 9395-9405
13. Kaiser E., Colescott R.L., Bossinger C.D., and Cook P.I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 34 (1970) 595-598
14. Kobayashi S., Takeshima K., Park C.B., Kim S.C., and Matsuzaki K. Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 39 (2000) 8648-8654
15. Krishnakumari V., and Nagaraj R. Interaction of antibacterial peptides spanning the carboxy-terminal region of human β-defensins 1-3 with phospholipids at the air-water interface and inner membrane of E. coli. Peptides 29 (2008) 7-14
16. Lehrer R.I., Barton A., Daher K.A., Harwig S.S.L., Ganz T., and Swlsted M.E. Interaction of human defensins with Escherichia coli-mechanism of bactericidal activity. J Clin Investig 84 (1989) 553-561
17. Li S.Z., Yan H.S., Liu G.D., Jiang L., and He B.L. Studies on synthesis and biological activities of analogues of melittin. Chem J Chin Univ 24 (2003) 449-453
18. Maloy W.L., and Kari U.P. Structure-activity studies on magainins and other host defense peptides. Biopolymers 37 (1995) 105-122
19. Manolios N., Collier S., Taylor J., Pollard J., Harrison L.C., and Bender V. T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. Nat Med 3 (1997) 84-88
20. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1462 (1999) 1-10
21. Oren Z., and Shai Y. Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 47 (1998) 451-463
22. Park C.B., Kim H.S., and Kim S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244 (1998) 253-257
23. Rausch J.M., Marks J.R., Rathinakumar R., and Wimley W.C. β-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes. Biochemistry 46 (2007) 12124-12139
24. Rausch J.M., Marks J.R., and Wimley W.C. Rational combinatorial design of pore-forming β-sheet peptides. Proc Natl Acad Sci USA 102 (2005) 10511-10515
25. Satoe K., Yutaka H., and Katsumi M. Bacteria-selective synergism between the antimicrobial peptides α-helical magainin 2 and cyclic β-sheet tachyplesin I: toward cocktail therapy. Biochemistry 40 (2001) 14330-14335
26. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462 (1999) 55-70
27. Sun X.J., Chen S.X., Li S.Z., Yan H.S., Fan Y.G., and Mi H.F. Deletion of two C-terminal Gln residues of 12-26-residue fragment of melittin improves its antimicrobial activity. Peptides 26 (2005) 369-375
28. Yan H.S., Li S.Z., Sun X.J., Mi H.F., and He B.L. Individual substitution analogs of Mel (12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. FEBS Lett 554 (2003) 100-104
29. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395